173 related articles for article (PubMed ID: 27543391)
21. Anti-proliferative effect and induction of apoptosis in androgen-independent human prostate cancer cells by 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one.
Citalingam K; Abas F; Lajis NH; Othman I; Naidu R
Molecules; 2015 Feb; 20(2):3406-30. PubMed ID: 25690296
[TBL] [Abstract][Full Text] [Related]
22. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells.
Srivastava JK; Gupta S
Biochem Biophys Res Commun; 2006 Jul; 346(2):447-53. PubMed ID: 16762318
[TBL] [Abstract][Full Text] [Related]
23. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.
Vue B; Zhang X; Lee T; Nair N; Zhang S; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4845-4854. PubMed ID: 28756013
[TBL] [Abstract][Full Text] [Related]
24. Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation.
Zhou DY; Ding N; Du ZY; Cui XX; Wang H; Wei XC; Conney AH; Zhang K; Zheng X
Mol Med Rep; 2014 Sep; 10(3):1315-22. PubMed ID: 25060817
[TBL] [Abstract][Full Text] [Related]
25. Novel curcumin analogue hybrids: Synthesis and anticancer activity.
Wang JQ; Wang X; Wang Y; Tang WJ; Shi JB; Liu XH
Eur J Med Chem; 2018 Aug; 156():493-509. PubMed ID: 30025345
[TBL] [Abstract][Full Text] [Related]
26. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents.
Ohtsu H; Xiao Z; Ishida J; Nagai M; Wang HK; Itokawa H; Su CY; Shih C; Chiang T; Chang E; Lee Y; Tsai MY; Chang C; Lee KH
J Med Chem; 2002 Nov; 45(23):5037-42. PubMed ID: 12408714
[TBL] [Abstract][Full Text] [Related]
27. 3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues.
Meng X; Cui L; Song F; Luan M; Ji J; Si H; Duan Y; Zhai H
Curr Comput Aided Drug Des; 2020; 16(3):245-256. PubMed ID: 30370853
[TBL] [Abstract][Full Text] [Related]
28. Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells.
Belluti S; Orteca G; Semeghini V; Rigillo G; Parenti F; Ferrari E; Imbriano C
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577600
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents.
Shi YK; Wang B; Shi XL; Zhao YD; Yu B; Liu HM
Eur J Med Chem; 2018 Feb; 145():11-22. PubMed ID: 29310026
[TBL] [Abstract][Full Text] [Related]
30. Effects of curcumin analogues for inhibiting human prostate cancer cells and the growth of human PC-3 prostate xenografts in immunodeficient mice.
Zhou DY; Ding N; Van Doren J; Wei XC; Du ZY; Conney AH; Zhang K; Zheng X
Biol Pharm Bull; 2014; 37(6):1029-34. PubMed ID: 24647337
[TBL] [Abstract][Full Text] [Related]
31. Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling.
Sha J; Li J; Wang W; Pan L; Cheng J; Li L; Zhao H; Lin W
Biomed Pharmacother; 2016 Dec; 84():177-184. PubMed ID: 27657825
[TBL] [Abstract][Full Text] [Related]
32. Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells.
Zhang X; Chen M; Zou P; Kanchana K; Weng Q; Chen W; Zhong P; Ji J; Zhou H; He L; Liang G
BMC Cancer; 2015 Nov; 15():866. PubMed ID: 26546056
[TBL] [Abstract][Full Text] [Related]
33. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
[TBL] [Abstract][Full Text] [Related]
35. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer.
Chen S; Nimick M; Cridge AG; Hawkins BC; Rosengren RJ
Int J Oncol; 2018 Feb; 52(2):579-588. PubMed ID: 29207190
[TBL] [Abstract][Full Text] [Related]
36. A monocarbonyl analogue of curcumin, 1,5-bis(3-hydroxyphenyl)-1,4-pentadiene-3-one (Ca 37), exhibits potent growth suppressive activity and enhances the inhibitory effect of curcumin on human prostate cancer cells.
Luo C; Li Y; Zhou B; Yang L; Li H; Feng Z; Li Y; Long J; Liu J
Apoptosis; 2014 Mar; 19(3):542-53. PubMed ID: 24297639
[TBL] [Abstract][Full Text] [Related]
37. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and Biological Evaluation of Curcumin Derivatives with Water-Soluble Groups as Potential Antitumor Agents: An in Vitro Investigation Using Tumor Cell Lines.
Ding L; Ma S; Lou H; Sun L; Ji M
Molecules; 2015 Dec; 20(12):21501-14. PubMed ID: 26633344
[TBL] [Abstract][Full Text] [Related]
39. Curcumin against Prostate Cancer: Current Evidence.
Termini D; Den Hartogh DJ; Jaglanian A; Tsiani E
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33182828
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and anticancer evaluation of long-chain alkoxylated mono-carbonyl analogues of curcumin.
Weng Q; Fu L; Chen G; Hui J; Song J; Feng J; Shi D; Cai Y; Ji J; Liang G
Eur J Med Chem; 2015 Oct; 103():44-55. PubMed ID: 26318057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
